Filing Details

Accession Number:
0001085146-25-001780
Form Type:
13G Filing
Publication Date:
2025-02-27 19:00:00
Filed By:
PATHSTONE FAMILY OFFICE, LLC
Company:
Nkgen Biotech Inc.
Filing Date:
2025-02-28
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
PATHSTONE FAMILY OFFICE, LLC 0 2,797,661 7.91%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Concentrated stock position owned by a client in a managed account.


SCHEDULE 13G


 
PATHSTONE FAMILY OFFICE, LLC
 
Signature:Rebecca A Judd
Name/Title:Director
Date:02/27/2025